T1	Participants 117 160	hypertensive patients with type 2 diabetes.
T2	Participants 208 329	hypertensive type-2 diabetic patients is associated with increased levels of circulating soluble adhesion molecules (SAM)
T3	Participants 553 591	hypertensive type-2 diabetic patients.
T4	Participants 600 662	Forty type-2 diabetic patients with never-treated hypertension
